Evidence for the presence of neutralizing antibodies against human papillomavirus type 6 in infants born to mothers with condyloma acuminata

American Journal of Perinatology

Volumn 20, Issue 1, 2003, Pages 11-15

  Kawana, Kei ^a   Yasugi, Toshiharu ^a   Yoshikawa, Hiroyuki ^b   Kawana, Yukiko ^a   Matsumoto, Koji ^a   Nakagawa, Shunsuke ^a   Onda, Takashi ^a   Kikuchi, Akihiko ^a   Fujii, Tomoyuki ^a   Kanda, Tadahito ^c   Taketani, Yuji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Condyloma acuminata; HPV; Neutralizing antibody

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MATERNAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS DNA;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CASE REPORT; CONDYLOMA ACUMINATUM; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 6; IMMUNOASSAY; MOUTH CAVITY; NEWBORN DISEASE; NONHUMAN; PREGNANCY COMPLICATION; PRIORITY JOURNAL; VERTICAL TRANSMISSION; VIRUS INFECTIVITY; WART VIRUS;

EID: 0037237669     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-37949     Document Type: Article

References (14)

1. Armstrong LR, Preston EJD, Reichert M, et al. Incidence and prevalence of recurrent respiratory papillomatosis among children in Atlanta and Seattle. Clin Infect Dis 2000;31:107-109
2. Shah KV, Kashima HK, Polk BF, Shah FK, Abby H, Abramson A. Rarity of cesarean delivery in cases of juvenile-onset respiratory papillomatosis. Obstet Gynecol 1986;68:795-799
3. Shah KV, Kashima HK. Prevention of juvenile-onset recurrent respiratory papillomas. Curr Opin Otolaryngol Head Neck Surg 1997;5:107-111
4. Kawana K, Yoshikawa H, Taketani Y, Yoshiike K, Kanda T. In vitro construction of pseudovirions of human papillomavirus type 16: incorporation of plasmid DNA into reassembled L1/L2 capsids. J Virol 1998;72:10298-10300
5. Kawana K, Kawana Y, Yoshikawa H, Taketani Y, Yoshiike K, Kanda T. Nasal immunization of mice with peptide having a cross-neutralization epitope on minor capsid protein L2 of human papillomavirus type 16 elicit systemic and mucosal antibodies. Vaccine 2001;19:1496-1502
6. Yeager MD, Aste-Amezaga M, Brown DR, et al. Neutralization of human papillomavirus (HPV) pseudovirions: a novel and efficient approach to detect and characterize HPV neuralizing antibodies. Virology 2000;570-577
7. Yoshikawa H, Kawana T, Kitagawa K, Mizuno M, Yoshikura H, Iwamoto A. Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers. Jpn J Cancer Res 1991;82:524-531
8. Matsumoto K, Yoshikawa H, Taketani Y, Yoshiike K, Kanda T. Antibodies to human papillomavirus 16, 18, 58, and 6b major capsid proteins among Japanese females. Jpn J Cancer Res 1997;88:369-375
9. Leiserowitz GS, Hall KS, Foster CA, et al. Detection of serologic neutralizing antibodies against HPV-11 in patients with condyloma acuminata and cervical dysplasia using an in vitro assay. Gynecol Oncol 1997;66:295-299
10. Harro CD, Pang YY, Roden RB, et al. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J Natl Cancer Inst 2001;93:284-292
11. Puranen M, Yliskoski M, Saarikoski S, Syrjanen K, Syrjanen S. Vertical transmission of human papillomavirus from infected mothers to their newborn babies and persistence of the virus in childhood. Am J Obstet Gynecol 1996;174:694-699
12. Pakarian F, Kaye J, Cason J, et al. Cancer associated human papillomavirus: perinatal transmission and persistence. Br J Obstet Gynecol 1994;101:514-517
13. Smith EM, Johnson SR, Cripe T, et al. Perinatal transmission and maternal risks of human papillomavirus infection. Cancer Detect Prev 1995;19:196-205
14. Prober CG, Sullender WM, Yasukawa LL, Au DS, Yeager AS, Arvin AM. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. N Engl J Med 1987;316:240-244.